Funding for this research was provided by:
Baldwin Foundation Breast Cancer Research Fund of Central New York
Received: 1 August 2022
Accepted: 20 January 2023
First Online: 24 January 2023
: This study was approved by the Institutional Review Board (IRB) for the protection of human subjects from SUNY Upstate Medical University, Syracuse, NY (#237231) and methods were in accordance with the 1964 Helsinki declaration and later amendments or comparable standards. All subjects have informed consent in written form to participate after detailed written and verbal explanation of the protocol. The orthopaedic oncologist (TAD) served as the principal investigator of the IRB application.
: Not applicable.
: The authors declare that there is no financial or no-financial competing interests with regards to the contents of this manuscript.